159 related articles for article (PubMed ID: 24486594)
61. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
62. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.
Zhu JS; Guo H; Song MQ; Chen GQ; Sun Q; Zhang Q
World J Gastroenterol; 2008 Oct; 14(38):5887-92. PubMed ID: 18855989
[TBL] [Abstract][Full Text] [Related]
63. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
[TBL] [Abstract][Full Text] [Related]
64. A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.
Garman KS; Acharya CR; Edelman E; Grade M; Gaedcke J; Sud S; Barry W; Diehl AM; Provenzale D; Ginsburg GS; Ghadimi BM; Ried T; Nevins JR; Mukherjee S; Hsu D; Potti A
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19432-7. PubMed ID: 19050079
[TBL] [Abstract][Full Text] [Related]
65. Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer.
Fjeldbo CS; Julin CH; Lando M; Forsberg MF; Aarnes EK; Alsner J; Kristensen GB; Malinen E; Lyng H
Clin Cancer Res; 2016 Aug; 22(16):4067-76. PubMed ID: 27012812
[TBL] [Abstract][Full Text] [Related]
66. Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature.
Thorsteinsson M; Kirkeby LT; Hansen R; Lund LR; Sørensen LT; Gerds TA; Jess P; Olsen J
Int J Colorectal Dis; 2012 Dec; 27(12):1579-86. PubMed ID: 22710688
[TBL] [Abstract][Full Text] [Related]
67. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
68. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
[TBL] [Abstract][Full Text] [Related]
69. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
[TBL] [Abstract][Full Text] [Related]
70. ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.
Vargas T; Moreno-Rubio J; Herranz J; Cejas P; Molina S; González-Vallinas M; Mendiola M; Burgos E; Aguayo C; Custodio AB; Machado I; Ramos D; Gironella M; Espinosa-Salinas I; Ramos R; Martín-Hernández R; Risueño A; De Las Rivas J; Reglero G; Yaya R; Fernández-Martos C; Aparicio J; Maurel J; Feliu J; Ramírez de Molina A
Oncotarget; 2015 Mar; 6(9):7348-63. PubMed ID: 25749516
[TBL] [Abstract][Full Text] [Related]
71. [Prognostic values of the clinical, morphological and molecular biological characteristics of colon adenocarcinoma].
Raskin GA; Pozharissky KM; Orlova RV; Petrov SV
Arkh Patol; 2015; 77(5):26-30. PubMed ID: 26978017
[TBL] [Abstract][Full Text] [Related]
72. Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.
Peng YH; Li JJ; Xie FW; Chen JF; Yu YH; Ouyang XN; Liang HJ
PLoS One; 2013; 8(10):e76693. PubMed ID: 24116137
[TBL] [Abstract][Full Text] [Related]
73. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
Zhou R; Zhang J; Zeng D; Sun H; Rong X; Shi M; Bin J; Liao Y; Liao W
Cancer Immunol Immunother; 2019 Mar; 68(3):433-442. PubMed ID: 30564892
[TBL] [Abstract][Full Text] [Related]
74. High
Zhou X; Shang YN; Lu R; Fan CW; Mo XM
Future Oncol; 2019 Jun; 15(18):2093-2106. PubMed ID: 31257922
[No Abstract] [Full Text] [Related]
75. Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation.
Huh JW; Kim SC; Sohn I; Jung SH; Kim HC
Oncotarget; 2016 Mar; 7(13):16338-48. PubMed ID: 26908450
[TBL] [Abstract][Full Text] [Related]
76. A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.
Peng JH; Fang YJ; Li CX; Ou QJ; Jiang W; Lu SX; Lu ZH; Li PX; Yun JP; Zhang RX; Pan ZZ; Wan de S
Oncotarget; 2016 Apr; 7(16):22939-47. PubMed ID: 27008710
[TBL] [Abstract][Full Text] [Related]
77. Candidate genes involved in metastasis of colon cancer identified by integrated analysis.
Zhou Y; Zang Y; Yang Y; Xiang J; Chen Z
Cancer Med; 2019 May; 8(5):2338-2347. PubMed ID: 30884206
[TBL] [Abstract][Full Text] [Related]
78. Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells.
Chen JT; Liu CC; Yu JS; Li HH; Lai MC
J Proteomics; 2018 Sep; 188():139-151. PubMed ID: 29524648
[TBL] [Abstract][Full Text] [Related]
79. New approaches but the same flaws in the search for prognostic signatures.
Salazar R; Tabernero J
Clin Cancer Res; 2014 Apr; 20(8):2019-22. PubMed ID: 24583802
[TBL] [Abstract][Full Text] [Related]
80. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
Sallinger K; Gruber M; Müller CT; Bonstingl L; Pritz E; Pankratz K; Gerger A; Smolle MA; Aigelsreiter A; Surova O; Svedlund J; Nilsson M; Kroneis T; El-Heliebi A
J Transl Med; 2023 Aug; 21(1):528. PubMed ID: 37543577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
